Avenue Therapeutics, Inc.
ATXI · OTC
Market closed$0.250000$0.00 (0.00%)After hours $0.250000 · 0.00%
Key statistics
Previous close$0.250000
Open$0.250000
Day high$0.250000
Day low$0.250000
52-week high$0.969900
52-week low$0.150000
Market cap823.74K
Volume1.00K
Average volume2.57K
P/E ratio-0.47
Forward P/E—
EPS-0.53
Dividend yield0.00%
Market context
Why it moved
ATXI shares showed no significant movement today, trading flat with minimal volume, as no major company-specific news or catalysts emerged to drive any directional price change.
What is happening
Recent company-specific developments and publisher coverage.
Pompe Disease News · February 26, 2026Avenue Therapeutics to develop add-on Pompe disease treatmentThe Wall Street Transcript · October 15, 2018Avenue Therapeutics (NASDAQ:ATXI) CEO and President Lucy Lu, M.D., has a Replacement for Medical OpiodsZacks Investment Research · October 4, 2018ATXI: No Pain? We See a Gain; Developing Tramadol Benzinga · May 8, 2026Avenue Therapeutics Q1 EPS $(0.21) Up From $(0.62) YoY